Wearable Electrochemical Sensors in Parkinson’s Disease

Parkinson’s disease (PD) is a neurodegenerative disorder associated with widespread aggregation of α-synuclein and dopaminergic neuronal loss in the substantia nigra pars compacta. As a result, striatal dopaminergic denervation leads to functional changes in the cortico-basal-ganglia-thalamo-cortica...

Full description

Bibliographic Details
Main Authors: Francesco Asci, Giorgio Vivacqua, Alessandro Zampogna, Valentina D’Onofrio, Adolfo Mazzeo, Antonio Suppa
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Sensors
Subjects:
Online Access:https://www.mdpi.com/1424-8220/22/3/951
_version_ 1797484781491978240
author Francesco Asci
Giorgio Vivacqua
Alessandro Zampogna
Valentina D’Onofrio
Adolfo Mazzeo
Antonio Suppa
author_facet Francesco Asci
Giorgio Vivacqua
Alessandro Zampogna
Valentina D’Onofrio
Adolfo Mazzeo
Antonio Suppa
author_sort Francesco Asci
collection DOAJ
description Parkinson’s disease (PD) is a neurodegenerative disorder associated with widespread aggregation of α-synuclein and dopaminergic neuronal loss in the substantia nigra pars compacta. As a result, striatal dopaminergic denervation leads to functional changes in the cortico-basal-ganglia-thalamo-cortical loop, which in turn cause most of the parkinsonian signs and symptoms. Despite tremendous advances in the field in the last two decades, the overall management (i.e., diagnosis and follow-up) of patients with PD remains largely based on clinical procedures. Accordingly, a relevant advance in the field would require the development of innovative biomarkers for PD. Recently, the development of miniaturized electrochemical sensors has opened new opportunities in the clinical management of PD thanks to wearable devices able to detect specific biological molecules from various body fluids. We here first summarize the main wearable electrochemical technologies currently available and their possible use as medical devices. Then, we critically discuss the possible strengths and weaknesses of wearable electrochemical devices in the management of chronic diseases including PD. Finally, we speculate about possible future applications of wearable electrochemical sensors in PD, such as the attractive opportunity for personalized closed-loop therapeutic approaches.
first_indexed 2024-03-09T23:09:23Z
format Article
id doaj.art-fe07c807ed184f5e9cf7ed8ba31f2356
institution Directory Open Access Journal
issn 1424-8220
language English
last_indexed 2024-03-09T23:09:23Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Sensors
spelling doaj.art-fe07c807ed184f5e9cf7ed8ba31f23562023-11-23T17:48:02ZengMDPI AGSensors1424-82202022-01-0122395110.3390/s22030951Wearable Electrochemical Sensors in Parkinson’s DiseaseFrancesco Asci0Giorgio Vivacqua1Alessandro Zampogna2Valentina D’Onofrio3Adolfo Mazzeo4Antonio Suppa5IRCCS Neuromed, 86077 Pozzilli, IS, ItalyIntegrated Research Center (PRAAB), Campus Biomedico University of Roma, Via Alvaro del Portillo 21, 00125 Rome, RM, ItalyDepartment of Human Neurosciences, Sapienza University of Rome, 00185 Rome, RM, ItalyDepartment of Human Neurosciences, Sapienza University of Rome, 00185 Rome, RM, ItalyDepartment of Human Neurosciences, Sapienza University of Rome, 00185 Rome, RM, ItalyIRCCS Neuromed, 86077 Pozzilli, IS, ItalyParkinson’s disease (PD) is a neurodegenerative disorder associated with widespread aggregation of α-synuclein and dopaminergic neuronal loss in the substantia nigra pars compacta. As a result, striatal dopaminergic denervation leads to functional changes in the cortico-basal-ganglia-thalamo-cortical loop, which in turn cause most of the parkinsonian signs and symptoms. Despite tremendous advances in the field in the last two decades, the overall management (i.e., diagnosis and follow-up) of patients with PD remains largely based on clinical procedures. Accordingly, a relevant advance in the field would require the development of innovative biomarkers for PD. Recently, the development of miniaturized electrochemical sensors has opened new opportunities in the clinical management of PD thanks to wearable devices able to detect specific biological molecules from various body fluids. We here first summarize the main wearable electrochemical technologies currently available and their possible use as medical devices. Then, we critically discuss the possible strengths and weaknesses of wearable electrochemical devices in the management of chronic diseases including PD. Finally, we speculate about possible future applications of wearable electrochemical sensors in PD, such as the attractive opportunity for personalized closed-loop therapeutic approaches.https://www.mdpi.com/1424-8220/22/3/951Parkinson’s diseaseL-Dopabiosensorswearable sensorselectrochemical monitoring
spellingShingle Francesco Asci
Giorgio Vivacqua
Alessandro Zampogna
Valentina D’Onofrio
Adolfo Mazzeo
Antonio Suppa
Wearable Electrochemical Sensors in Parkinson’s Disease
Sensors
Parkinson’s disease
L-Dopa
biosensors
wearable sensors
electrochemical monitoring
title Wearable Electrochemical Sensors in Parkinson’s Disease
title_full Wearable Electrochemical Sensors in Parkinson’s Disease
title_fullStr Wearable Electrochemical Sensors in Parkinson’s Disease
title_full_unstemmed Wearable Electrochemical Sensors in Parkinson’s Disease
title_short Wearable Electrochemical Sensors in Parkinson’s Disease
title_sort wearable electrochemical sensors in parkinson s disease
topic Parkinson’s disease
L-Dopa
biosensors
wearable sensors
electrochemical monitoring
url https://www.mdpi.com/1424-8220/22/3/951
work_keys_str_mv AT francescoasci wearableelectrochemicalsensorsinparkinsonsdisease
AT giorgiovivacqua wearableelectrochemicalsensorsinparkinsonsdisease
AT alessandrozampogna wearableelectrochemicalsensorsinparkinsonsdisease
AT valentinadonofrio wearableelectrochemicalsensorsinparkinsonsdisease
AT adolfomazzeo wearableelectrochemicalsensorsinparkinsonsdisease
AT antoniosuppa wearableelectrochemicalsensorsinparkinsonsdisease